x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001092
| Product Information | |
|---|---|
| Product Name | Human Estrogen Receptorβ ELISA Kit |
| Species | Human |
| Description | This estrogen receptor-β ELISA kit is a sandwich ELISA assay for the quantitative measurement of human estrogen receptor-β in serum, plasma and cell culture supernatants. The density of color is proportional to the amount of human estrogen receptor-β captured from the samples. |
| Sample Types | Serum, Plasma, Tissue Homogenate |
| Detection Range | 0.313 ng/mL - 20 ng/mL |
| Sensitivity | < 0.188 ng/mL |
| Target Information | |
|---|---|
| Target Name | ESR2 |
| UniProt No. | Q92731 |
| Gene ID | 2100 |
| Target Description | Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner. Isoformβ-cx lacks ligand binding ability and has no or only very low ere binding activity resulting in the loss of ligand-dependent transactivation ability. DNA-binding by ESR1 and ESR2 is rapidly lost at 37 degrees Celsius in the absence of ligand while in the presence of 17β-estradiol and 4-hydroxy-tamoxifen loss in DNA-binding at elevated temperature is more gradual. |
| Alternative Names | ERβ; ER-β; Erb; ESR B; ESRβ; ESR2; ESR2_HUMAN; ESRB; ESTRB; estrogen nuclear receptorβ variant a; estrogen nuclear receptorβ variant b; Estrogen receptor 2; estrogen receptor 2 (ERβ); Estrogen receptorβ; estrogen receptorβ 4; NR3A2; Nuclear receptor subfamily 3 group A member 2 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
